Related Experiment Videos
Prognostic value of ovarian carcinoma grading methods--a method comparison study
H Haapasalo1, Y Collan, A Seppä
1Department of Pathology, University of Kuopio, Finland.
Histopathology
|January 1, 1990
Summary
This study compared histological and morphometric grading for ovarian cancer prognosis. The mitotic index (M/V-index) showed superior prognostic power compared to other methods.
Area of Science:
- Oncology
- Pathology
- Medical Statistics
Background:
- Accurate prognostic assessment is crucial for primary ovarian carcinomas.
- Histological and morphometric grading methods are used to predict patient outcomes.
- Reproducibility and prognostic power of different grading systems require evaluation.
Purpose of the Study:
- To compare the prognostic value of subjective histological grading (Czernobilsky, Russell) and morphometric grading (Baak) in primary ovarian carcinomas.
- To evaluate the prognostic power of mitotic counting (volume corrected mitotic index, M/V-index) against established grading methods.
- To assess the reproducibility of the morphometric grading and M/V-index methods.
Main Methods:
- Seventy-five primary ovarian carcinomas were analyzed.
- Histological grading by Czernobilsky and Russell methods, and morphometric grading by Baak's method were performed by two observers.
- Mitotic counting (M/V-index) was assessed and compared using receiver operating characteristic (ROC) curves.
Main Results:
- All three grading methods (Czernobilsky, Russell, Baak) predicted 5-year survival in approximately two-thirds of patients.
- The M/V-index demonstrated superior prognostic power compared to histological and morphometric grading across various sensitivity/specificity levels.
- Both the morphometric grading method and the M/V-index method exhibited good reproducibility.
Conclusions:
- While subjective histological and morphometric grading offer some prognostic value, the M/V-index is a more powerful predictor of survival in ovarian cancer.
- The M/V-index is a reproducible and superior method for prognostic assessment in primary ovarian carcinomas.
- Further validation of the M/V-index in larger cohorts is warranted.